One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis
Jeffrey S Hyams, MD, Michael Brimacombe, PhD, Yael Haberman, MD, PhD, Thomas Walters, MD, Greg Gibson, PhD, Angela Mo, PhD, David Mack, MD, Anne Griffiths, MD, Brendan Boyle, MD, Neal LeLeiko, MD, PhD, James Markowitz, MD, Joel Rosh, MD, Ashish Patel, MD, Sapana Shah, MD, Robert Baldassano, MD, Marian Pfefferkorn, MD, Cary Sauer, MD, Joelynn Dailey, DO, Suresh Venkateswaran, PhD, Subra Kugathasan, MD, Lee A Denson, MD
doi : 10.1093/ibd/izab061
Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model
Laura A Johnson, BS, Eva S Rodansky, MS, Anhdao Tran, MS, Stephen G Collins, MS, Kathryn A Eaton, DVM, PhD, Benjamin Malamet, MS, Calen A Steiner, MD, Sha Huang, MS, Jason R Spence, PhD, Peter D R Higgins, MD, PhD, MS
doi : 10.1093/ibd/izab166
Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
Christina Santella, MSc, Alain Bitton, MD, Christopher Filliter, MSc, Talat Bessissow, MD, MSc, Maria Vutcovici, MSc, Peter L Lakatos, MD, PhD, Paul Brassard, MD, MSc
doi : 10.1093/ibd/izab092
Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission
Luca Scarallo, MD, Giulia Bolasco, MD, Jacopo Barp, MD, Martina Bianconi, MD, Monica di Paola, PhD, Michele Di Toma, MD, Sara Naldini, MD, Monica Paci, MD, Sara Renzo, MD, Flavio Labriola, MD, Salvatore De Masi, MD, Patrizia Alvisi, MD, Paolo Lionetti, MD, PhD
doi : 10.1093/ibd/izab046
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Laura E Raffals, MD, MS, Sumona Saha, MD, MS, Meenakshi Bewtra, MD, Cecile Norris, MFA, Angela Dobes, MPH, Caren Heller, MD, MBA, Sirimon O’Charoen, PhD, Tara Fehlmann, MHS, Sara Sweeney, Alandra Weaver, MPH, Shrinivas Bishu, MD, Raymond Cross, MD, Themistocles Dassopoulos, MD, Monika Fischer, MD, MSc, Andres Yarur, MD, David Hudesman, MD, Deepak Parakkal, MD, Richard Duerr, MD, Freddy Caldera, MD, Joshua Korzenik, MD, Joel Pekow, MD, Katerina Wells, MD, Matthew Bohm, MD, Lilani Perera, MD, Manreet Kaur, MD, Matthew Ciorba, MD, Scott Snapper, MD, Elizabeth A Scoville, MD, Sushila Dalal, MD, Uni Wong, MD, James D Lewis, MD
doi : 10.1093/ibd/izab071
Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
Kunio Asonuma, MD, PhD, Taku Kobayashi, MD, PhD, Masaru Nakano, MD, PhD, Shintaro Sagami, MD, PhD, Hiroki Kiyohara, MD, PhD, Mao Matsubayashi, MD, Hiromu Morikubo, MD, Yusuke Miyatani, MD, Shinji Okabayashi, MD, Hajime Yamazaki, MD, PhD, Yuichiro Kuroki, MD, PhD, Toshifumi Hibi, MD, PhD
doi : 10.1093/ibd/izab062
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases
Claire Liefferinckx, MD, PhD, Jérémie Bottieau, Jean-François Toubeau, PhD, Debby Thomas, PhD, Jean-François Rahier, MD, PhD, Edouard Louis, MD, PhD, Filip Baert, MD, PhD, Pieter Dewint, MD, Lieven Pouillon, MD, Guy Lambrecht, MD, François Vallée, PhD, Severine Vermeire, MD, PhD, Peter Bossuyt, MD, Denis Franchimont, MD, PhD Belgian Inflammatory Bowel Disease Research and Development Group
doi : 10.1093/ibd/izab042
Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn’s Disease
Hadrien Alric, MD, Aurélien Amiot, MD, PhD, Julien Kirchgesner, MD, PhD, Xavier Tréton, MD, PhD, Mathieu Allez, MD, PhD, Yoram Bouhnik, MD, PhD, Laurent Beaugerie, MD, PhD, Franck Carbonnel, MD, PhD, Antoine Meyer, MD
doi : 10.1093/ibd/izab060
Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study
Jeffrey D McCurdy, MD, PhD, Jacqueline Reid, MD, Russell Yanofsky, MD, Vigigah Sinnathamby, Edgar Medawar, MD, Lara Williams, MD, Talat Bessissow, MD, Greg Rosenfeld, MD
doi : 10.1093/ibd/izab086
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Nonmelanoma Skin Cancer Rates From the Ulcerative Colitis Clinical Program
Bruce E Sands, MD, MS, Millie D Long, MPH, Walter Reinisch, MD, Julian Panés, MD, PhD, Edward V Loftus, Jr, MD, Chudy I Nduaka, DVM, PhD, Arif Soonasra, PharmD, Rajiv Mundayat, MSc, Nervin Lawendy, PharmD, Gary Chan, PharmD, MS, Gary S Friedman, MD, Chinyu Su, MD
doi : 10.1093/ibd/izab056
Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn’s Disease
Aito Ueno, PhD, Humberto B Jijon, MD, PhD, Richard Peng, Steven Sparksman, MSc, Barbara Mainoli, BSc, Alexis Filyk, Yan Li, MSc, Stephanie Wilson, MD, Kerri Novak, MD, Remo Panaccione, MD, Simon Hirota, PhD, Antoine Dufour, PhD, Cathy Lu, MD, Paul L Beck, MD, PhD
doi : 10.1093/ibd/izab157
Characterization of Skeletal Phenotype and Associated Mechanisms With Chronic Intestinal Inflammation in the Winnie Mouse Model of Spontaneous Chronic Colitis
Ahmed Al Saedi, PhD, Shilpa Sharma, MSc, Ebrahim Bani Hassan, PhD, Lulu Chen, PhD, Ali Ghasem-Zadeh, PhD, Majid Hassanzadeganroudsari, MSc, Jonathan H Gooi, PhD, Rhian Stavely, PhD, Rajaraman Eri, PhD, Dengshun Miao, MD, PhD, Kulmira Nurgali, PhD, Gustavo Duque, MD, PhD
doi : 10.1093/ibd/izab174
Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis
Yan Xu, Yuxi Tian, PhD, Fujun Li, PhD, Ying Wang, MD, Junwen Yang, PhD, Hui Gong, MD, Xiaoping Wan, PhD, Miao Ouyang, PhD
doi : 10.1093/ibd/izab188
Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance
Benjamin Click, MD, MS, Amit Merchea, MD, Dorin T Colibaseanu, MD, Miguel Regueiro, MD, Francis A Farraye, MD, MSc, Luca Stocchi, MD
doi : 10.1093/ibd/izab081
The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis
Babajide A Ojo, PhD, Kelli L VanDussen, PhD, Michael J Rosen, MD, MSCI
doi : 10.1093/ibd/izab161
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn’s Disease
Scott David Lee, MD, Anand Singla, MD, Jason Harper, MD, Mitra Barahimi, MD, Jeffrey Jacobs, MD, Kendra J Kamp, RN, PhD, Kindra Dawn Clark-Snustad, DNP
doi : 10.1093/ibd/izab176
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry
Ryan C Ungaro, MD, MS, Manasi Agrawal, MD, Erica J Brenner, MD, Xian Zhang, PhD, Jean-Frederic Colombel, MD, Michael D Kappelman, MD, MPH, Walter Reinisch, MD
doi : 10.1093/ibd/izab184
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice
David M Alvarado, PhD, Juhee Son, BS, Larissa B Thackray, PhD, Maria Florencia Gomez Castro, PhD, Sarada Prasad, BS, Xueyang Cui, MD, Naomi M Sonnek, MS, Michael S Diamond, MD, PhD, Siyuan Ding, PhD, Matthew A Ciorba, MD
doi : 10.1093/ibd/izab274
Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working
Jeremy Adler, MD, MSc, Grace J Lee, MD, Andrew A M Singer, MD
doi : 10.1093/ibd/izab047
The Difficulty of Distal Crohn’s Disease and the Utility of Diverting Stomas
Nicole Elizabeth Kiefer Wieghard, MD, FACS, FASCRS
doi : 10.1093/ibd/izab146
Fistula Healing Is Low After Fecal Diversion Surgery in Perianal Crohn’s Disease
Sheeva Johnson, MD, MPH, Jeffrey Ko, MD, Wissam J Halabi, MD, Jesse Stondell, MD, Maneesh Dave, MD, MPH
doi : 10.1093/ibd/izab210
Simultaneous Development of Ulcerative Colitis in the Sigmoidocolon Autotransplant Neovagina and the Residual Colorectum
Yusuke Matsune, MD, Katsuki Yaguchi, MD, Shin Saito, MD, PhD, Hideya Sakakibara, MD, PhD, Yoshiaki Inayama, MD, PhD, Hideaki Kimura, MD, PhD, Reiko Kunisaki, MD, PhD
doi : 10.1093/ibd/izab222
Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19
Xianqiang Yu, PhD
doi : 10.1093/ibd/izab223
Herpes Zoster in a Patient With Ulcerative Colitis After Vedolizumab Initiation—Causal Link or Only Temporal Coincidence?
Na Wu, MD, Hua Li, PhD, Jinyan Zhang, MD, Weifeng Huang, PhD
doi : 10.1093/ibd/izab229
Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib
Shubhra Mishra, MD, Anupam Kumar Singh, MD, Chirag Kopp, DM, Anuraag Jena, MD, Vishal Sharma, MD
doi : 10.1093/ibd/izab234
Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn’s Disease Under Anti-TNF Therapy
Parna Moghadam, MD, Marc Dumas, MD, Laurent Blum, MD, Isabel Gimenez, MD, Pascale Hervio, MD, Edouard Begon, MD
doi : 10.1093/ibd/izab235
Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study
Xiaoyu Gu, BS, Xinchen Ke, BS, Minxue Shen, PhD, Mi Zhang, MD, Juan Su, MD
doi : 10.1093/ibd/izab240
EQUIVALENT ADVERSE OUTCOMES FOR HOME AND HOSPITAL-BASED INFUSIONS OF INFLIXIMAB IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
Shivani Gupta, Josh Bricker, Brendan Boyle, Ross Maltz, Hilary Michel, Jennifer Dotson
doi : 10.1093/ibd/izac015.000
AHR EXPRESSION ON VIL1-EXPRESSING COLONIC EPITHELIAL CELLS IS ESSENTIAL FOR I3C-MEDIATED PROTECTION AGAINST COLITIS
Archana Saxena, Chandani Mitchell, Shanieka Stanley, Keisha Wilson, Alex Rutkovsky, P J Wisniewski, Nicholas Dopkins, Mitzi Nagarkatti, Prakash Nagarkatti, Philip Busbee
doi : 10.1093/ibd/izac015.001
AUPHOS, A “FIRST-IN CLASS“ ORAL AGENT FOR CORRECTING METABOLIC DYSFUNCTION IN IBD
Lesley Wempe, Rana Mohamed, James Warinner, Tatiana Goretsky, Margarita Avdiushko, Jong Kim, Ahmed Abomhya, Goo Lee, Samuel Awuah, Terrence Barrett, Neeraj Kapur
doi : 10.1093/ibd/izac015.002
AUPHOS, A NOVEL THERAPEUTIC THAT IMPROVES MITOCHONDRIAL FUNCTION AND AMELIORATES CHRONIC COLITIS
Rana Mohamed, James Warinner, Lesley Wempe, Margarita Avdiushko, Tatiana Goretsky, Jong Kim, Ahmed Abomhya, Goo Lee, Samuel Awuah, Terrence Barrett, Neeraj Kapur
doi : 10.1093/ibd/izac015.003
CELL-AUTONOMOUS HEDGEHOG SIGNALING CONTROLS TH17 DIFFERENTIATION TO DRIVE INTESTINAL INFLAMMATION AND IS A DRUGGABLE TARGET FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Joachim Hanna, Flavio Beke, Louise O’Brien, Chrysa Kapeni, Hung-Chang Chen, Valentina Carbonaro, Alexander Kim, Timon E Adolph, Mikkel-Ole Skjoedt, Skjoedt Karsten, Marc de la Roche, Maike de la Roche
doi : 10.1093/ibd/izac015.004
CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SODIUM SULFATE (DSS)-INDUCED COLITIS IN RATS
Priyanka Dhingra, Alison Obr, Carl Spana, John Dodd, Paul Kayne
doi : 10.1093/ibd/izac015.005
DIET AND ITS MICROENVIRONMENT INFLUENCE THE HEALTH OF COLON
Sunil Thomas, Giancarlo Mercogliano, George Prendergast
doi : 10.1093/ibd/izac015.006
DISCOVERY OF IBD3540: A NOVEL GUT-RESTRICTED GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR WITH ORAL ACTIVITY IN MOUSE COLITIS MODELS
Diane Peters, Lauren Norris, Lukas Tenora, Ivan Snajdr, Xiaolei Zhu, Shinji Sakamoto, Ajit Thomas, Pavel Majer, Rana Rais, Barbara Slusher
doi : 10.1093/ibd/izac015.007
GENERATION OF ANTIGEN-SPECIFIC REGULATORY T CELLS BYLACTOBACILLUS SPECIES
Alexa Weingarden, Djenet Bousbaine, Yiyin Chen, Michael Fischbach
doi : 10.1093/ibd/izac015.008
LACTOCOCCUS LACTIS DELIVERY OF SURFACE LAYER PROTEIN A PROTECTS MICE FROM COLITIS BY RE-SETTING HOST IMMUNE REPERTOIRE
Bikash Sahay
doi : 10.1093/ibd/izac015.009
MTADV 5-MER PEPTIDE SUPPRESSES IBD PATHOLOGY AND UNVEILS A NEW POTENTIAL TARGET-SERUM AMYLOID A
David Naor, Mary Cowman, Jin Kim, Maayan Hemed-Shaked
doi : 10.1093/ibd/izac015.010
ORAL ADMINISTRATION OF NANOLIPOSOMES LOADED M13 MAY TREAT ULCERATIVE COLITIS AND COLITIS-ASSOCIATED CANCER WITHOUT CAUSING ANY SIDE EFFECTS
Dingpei Long, Chunhua Yang, Zahra Alghoul, Junsik Sung, Didier Merlin
doi : 10.1093/ibd/izac015.011
TOFACITINIB TREATMENT PREVENTS POST-OPERATIVE RECURRENCE OF CROHN’S DISEASE MODELED BY ILEOCECAL RESECTION IN HLA-B27 TRANSGENIC RATS
Aurélie Blondeaux, Silvia Speca, Caroline Valibouze, Thomas Lambin, Caroline Dubuquoy, Marie Titecat, Helene Blanquart, Christel Neut, Michael Genin, Philippe Zerbib, Benoit Foligne, Pierre Desreumaux
doi : 10.1093/ibd/izac015.012
ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY
Noa Cleveland, Benjamin Chastek, Tito Ghosh, Ninfa Candela, Timothy Bancroft, Tao Fan, Kandavadivu Umashankar, David Rubin
doi : 10.1093/ibd/izac015.013
ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY
Noa Cleveland, Benjamin Chastek, Tito Ghosh, Ninfa Candela, Timothy Bancroft, Tao Fan, Kandavadivu Umashankar, David Rubin
doi : 10.1093/ibd/izac015.014
DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NA�VE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY
Niranjan Kathe, Kandavadivu Umashankar, Kirti Mirchandani, Arunima Hait, Riyanka Paul, Tito Ghosh, Ninfa Candela, Tao Fan
doi : 10.1093/ibd/izac015.015
EFFECTIVENESS OF ANTI-TNF THERAPY COMPARED TO IMMUNE MODULATOR FOR PREVENTION OF SURGICAL RECURRENCE IN PEDIATRIC CD
Matthew Egberg, Xian Zhang, Michael Phillips, Michael Kappelman
doi : 10.1093/ibd/izac015.016
EFFICACY OF BIOLOGIC DRUGS IN SHORT-DURATION VERSUS LONG-DURATION INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND INDVIDUAL-PATIENT-DATA METANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Shomron Ben-Horin, Lena Novack, Ren Mao, Jing Guo, Yue Zhao, Ruslan Sergienko, Jian Zhang, Taku Kobayashi, Toshihumi Hibi, Yehuda Chowers, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Gilaad Kaplan, Min-Hu Chen
doi : 10.1093/ibd/izac015.017
IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS
Frank Scott, Anita Afzali, Parambir Dulai, Mei Lu, Ninfa Candela, Tao Fan, Tito Ghosh, James Lewis
doi : 10.1093/ibd/izac015.018
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Muhammad Khan, Kamran Mushtaq, Muhammad Saddique, Mohd Alghizzawi, Muhammad Yasir, Hafiz Younis, Farah Rashid, Deema AlSoub, Rafie Yakoob, Saad AlKaabi, Khalid Al-Ejji
doi : 10.1093/ibd/izac015.019
ADDITIVE EFFECT OF PROBIOTICS ON 5-AMINOSALICYLIC ACID THERAPY IN PATIENT WITH ULCERATIVE COLITIS
Minjun Kim
doi : 10.1093/ibd/izac015.020
CORTICOSTEROIDS AND 5ASA VERSUS CORTICOSTEROIDS ALONE FOR ACUTE SEVERE ULCERATIVE COLITIS: A RANDOMIZED CONTROLLED TRIAL
Shomron Ben-Horin, Ofir Har-Noy, Konstantinos Katsanos, Xavier Roblin, Min-Hu Chen, Xiang Gao, Doron Schwartz, Jae Hee Cheon, Monica Cesarini, Daniela Bojic, Marijana Protic, Angeliki Theodoropoulou, Heba Abu-Kaf, Tal Engel, Jian Tang, Pauline Veyrard, Xiaoqing Lin, Ren Mao, Dimitrios Christodoulou, Konstantinos Karmiris, Tamara Knezevic-Ivanovski
doi : 10.1093/ibd/izac015.021
MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
David Rubin, Paul Pollack, Theresa Hunter, Mingyang Shan, Lai-Shan Chan, Deanilee Deckard
doi : 10.1093/ibd/izac015.022
MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Edward Loftus, Paul Pollack, Theresa Hunter, Mingyang Shan, Lai-Shan Chan, Deanilee Deckard, Raymond Cross
doi : 10.1093/ibd/izac015.023
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OZANIMOD IN ULCERATIVE COLITIS
Daniel Tatosian, Jun Shen, Lu Chen, Jean Lavigne, Nathan Teuscher, Sarah Harris, Denesh Chitkara, Giridhar Tirucherai, Cecilia Marta
doi : 10.1093/ibd/izac015.024
POPULATION PHARMACOKINETICS OF OZANIMOD AND ACTIVE METABOLITE CC112273 IN PATIENTS WITH ULCERATIVE COLITIS
Jun Shen, Daniel Tatosian, Lamia Sid-Otmane, Nathan Teuscher, Lu Chen, Peijin Zhang, Giridhar Tirucherai, Denesh Chitkara, Cecilia Marta
doi : 10.1093/ibd/izac015.025
SAFFRON AS AN ADJUVANT THERAPY IN ULCERATIVE COLITIS PATIENTS
Hassan Ashktorab, Philip Oppong-Twene, Holden Terry Maecker, Lakshmi Chirumamilla, Angesom Kibreab, Eiman Nabi, Adeyinka Laiyemo, Hassan Brim
doi : 10.1093/ibd/izac015.026
INTERLEUKIN-17 RECEPTOR SIGNALING TO PANETH CELLS HELPS MAINTAIN INTESTINAL INTEGRITY AFTER GAMMA RADIATION INDUCED INJURY
Cody Kempen, Stephen Gaudino, Tej Bahadur, Ankita Singh, Pawan Kumar
doi : 10.1093/ibd/izac015.027
THE USE OF IMMUNOSTAINING IN BIOPSIES TO EVALUATE EXPRESSION PATTERN AND PATHOPHYSIOLOGY ROLES OF ONCOSTATIN M AND ITS RECEPTOR BETA IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Jonathan Beri, Zhaoping He, Kudakwashe Chikwava, Zarela Molle-Rios
doi : 10.1093/ibd/izac015.028
AUTOMATIC BLEEDING AND ULCER DETECTION FROM LIMITED QUALITY ANNOTATIONS IN ULCERATIVE COLITIS
Safaa Al-Ali, John Chaussard, Sébastien Li-Thiao-Té, Eric Ogier-Denis, Alice Percy-du-sert, Xavier Treton, Hatem Zaag
doi : 10.1093/ibd/izac015.029
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING TOOL FOR EARLY DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE IN THE PRIMARY CARE SETTING: A POPULATION BASED STUDY
Tahel Ilan Ber, Amir Ben Tov, Sivan Gazit, Shlomit Steinberg-Koch, Benny Getz, Yonatan Jenudi, Dan Underberger, Or Ramni, Shomron Ben-Horin
doi : 10.1093/ibd/izac015.030
REAL-TIME CONTINUOUS REPORTING OF IBD BIOMARKERS IN SWEAT
Badrinath Jagannath, Madhavi Pali, Kai-chun Lin, Devangsingh Sankhala, Abha Sardesai, Sriram Muthukumar, Shalini Prasad
doi : 10.1093/ibd/izac015.031
RISK FACTORS FOR DEVELOPMENT OF PROSTATE CANCER IN PATIENT WITH INFLAMMATORY BOWEL DISEASE (IBD)
Ishaan Jakhar, Medha Singh, Suman Sahil, Annapoorna Singh, Daulath Singh
doi : 10.1093/ibd/izac015.032
THE ASSESSMENT OF MRE FINDINGS ACCORDING TO CDAI SCORE IN PATIENTS WITH CROHN’S DISEASE
Monika Zbroja, Maryla Kuczynska, Weronika Cyranka, Malgorzata Nowakowska, Magdalena Grzegorczyk, Karolina Siejka, Monika Piekarska
doi : 10.1093/ibd/izac015.033
UTILITY OF FIBROSCAN IN ULCERATIVE COLITIS?
Shubham Jain, Sujit Nair, Sanjay Chandnani, Parmeshwar Junare, Prasanta Debnath, Siddhesh Rane, Sameet Patel, Pravin Rathi
doi : 10.1093/ibd/izac015.034
WHEN CROHN’S COMES TO RADIOLOGIST- THE ROLE OF MR ENTEROGRAPHY (MRE) IN THE DIAGNOSIS OF PENETRATING CROHN’S DISEASE IN PEDIATRIC AND ADULT PATIENTS
Weronika Cyranka, Maryla Kuczynska, Monika Zbroja, Malgorzata Nowakowska, Monika Piekarska, Karolina Siejka, Magdalena Grzegorczyk
doi : 10.1093/ibd/izac015.035
AMINO ACID SENSING PATHWAYS IN INFLAMMATORY BOWEL DISEASE
Sumeet Solanki, Jun-Hee Lee, Yatrik Shah
doi : 10.1093/ibd/izac015.036
DIET-ASSOCIATED INFLAMMATION, PHYSICAL ACTIVITY, AND HEALTH-RELATED OUTCOMES IN ULCERATIVE COLITIS
Kelli DuBois, Christine Blake, Caroline Rudisill, Sayward Harrison, James Hébert
doi : 10.1093/ibd/izac015.037
EFFECTIVENESS OF CROHN’S DISEASE EXCLUSION DIET FOR INDUCTION OF REMISSION IN CROHN’S DISEASE ADULT PATIENTS
Martyna Szczubelek, Karolina Pomorska, Monika Korólczyk-Kowalczyk, Konrad Lewandowski, Magdalena Kaniewska, Grazyna Rydzewska
doi : 10.1093/ibd/izac015.038
EFFICACY OF A DIGITALLY DELIVERED PERSONALIZED ELIMINATION DIET FOR THE SELF-MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME
Samuel Jactel, Joseph Olson, Jordan Brown, Kathleen Wolin, Valerie Jagiella
doi : 10.1093/ibd/izac015.039
LONG TERM OUTCOMES OF PARTIAL ENTERAL NUTRITION THERAPY IN CHILDREN WITH CROHN’S DISEASE
Srisindu Vellanki, Anthony Borcich, Atu Agawu, Natalie Stoner, Albenberg Lindsey
doi : 10.1093/ibd/izac015.040
MY SCD PROTOCOL - AN ONLINE, COMPREHENSIVE, REMOTELY-SUPERVISED PROTOCOL FOR IBD PATIENTS TO IMPLEMENT AN EFFECTIVE DIETARY INTERVENTION
Ali Arjomand, Rachelle Caviness
doi : 10.1093/ibd/izac015.041
NOVEL INSIGHTS INTO THE MECHANISM OF ACTION OF EXCLUSIVE ENTERAL NUTRITION IN CROHN’S DISEASE: PRE-CLINICAL STUDY IN A RODENT MODEL OF CROHN’S-LIKE COLITIS
Ramasatyaveni Geesala, You-Min Lin, Ke Zhang, Amosy M’Koma, Steven Cohn, Xuan-Zheng Shi
doi : 10.1093/ibd/izac015.042
SELECTIVELY IMPROVEMENT OF THE RESPONSE OF IMMUNE CELLS TO OPPORTUNISTIC MICROORGANISMS: AN INNOVATIVE PROPOSAL FOR IBD FROM AN ANCIENT GRAIN
Sergio Pumarola Segura
doi : 10.1093/ibd/izac015.043
SIMPLE SUGAR TRIGGERS SPONTANEOUS COLITIS DEVELOPMENT INIL10-/- MICE
Shahanshah Khan, Hasan Zaki
doi : 10.1093/ibd/izac015.044
THE EFFECTS OF HIGH-FAT, LOW-FAT, AND SUCROSE-FREE DIETS ON MICE WITH INNATE IMMUNE MEDIATED COLITIS
Katelyn Ruley-Haase, Antonia Boger-May, Alvaro Torres Huerta, David Boone, Theodore Reed, Arpitha Mysore Rajashekara, Cameron Pederson, Ese-Onosen Omoijuanfo, Annie Cate Scmidt
doi : 10.1093/ibd/izac015.045
ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC
Malika Waschmann, Ariana Stuart, Henry Lin, Anna Hunter
doi : 10.1093/ibd/izac015.046
ADEQUACY OF SIGMOIDOSCOPY IN COMPARISION TO COLONOSCOPY TO ASSESS DISEASE ACTIVITY DURING FOLLOW UP IN PATIENTS WITH ULCERATIVE COLITIS
Sameet Patel, Shubham Jain, Sanjay Chandnani, Prasanta Debnath, Qais Contractor, Seemily Kahmei, Rima Kamat, Pravin Rathi
doi : 10.1093/ibd/izac015.047
CORRELATION OF FECAL, PLASMA, SERUM, AND SALIVARY CALPROTECTIN TO ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN PATIENTS WITH CROHN’S DISEASE
Kendra Kamp, Kindra Clark-Snustad, Kamil Saad, Ernie Tolentino, Margaret Heitkemper, Neelendu Dey, Sean Gui, Scott D Lee
doi : 10.1093/ibd/izac015.048
CORRELATION OF PUCAI BETWEEN MAYO ENDOSCOPIC AND GEBOES PATHOLOGY SCORES IN ASSESSING DISEASE ACTIVITY OF PEDIATRIC PATIENTS WITH UC AMONG HISPANICS AND NON-HISPANICS
Francisco Durazo, Sonia Michail
doi : 10.1093/ibd/izac015.049
INFLAMMATORY BOWEL DISEASE RISK STRATIFICATION AND MANAGEMENT IN A COMMUNITY PRACTICE SETTING
Angelina Collins, Sadie Swift, Adam Recht, Rose Prime, Robert Topp, Svetlana Beltyukova, Robert Goldklang, Franklin Gaylis
doi : 10.1093/ibd/izac015.050
POINT-OF-CARE INTESTINAL ULTRASOUND FOR THE DETECTION OF POSTOPERATIVE CROHN’S DISEASE ENDOSCOPIC RECURRENCE
Michael Dolinger, Zachary Stauber, Elizabeth Spencer, Maia Kayal, Nanci Pittman, Jean-Frederic Colombel, Marla Dubinsky
doi : 10.1093/ibd/izac015.051
TOWARDS A COMMON VALIDATED METHODOLOGY FOR HISTOLOGIC MEASUREMENT OF MUCOSAL HEALING IN ULCERATIVE COLITIS: INTRODUCING A NEW PROJECT OF THE BIOMARKERS CONSORTIUM OF THE FOUNDATION FOR THE NIH
Gerard Honig
doi : 10.1093/ibd/izac015.052
VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA
Jeremy Adler, Richard Colletti, Lenore Noonan, Laurie Conklin, Kim Hung Lo, Yongling Xiao, Sheri Volger
doi : 10.1093/ibd/izac015.053
ANEMIA TREATMENT PATTERNS AND OUTCOMES AMONG A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Carolyn Brooks, Shubhada Sansgiry, Jason Hou
doi : 10.1093/ibd/izac015.054
BURDEN OF ILLNESS OF OSTEOPOROTIC FRACTURES COMPARED TO OTHER SERIOUS DISEASES AMONG IBD PATIENTS
Raseen Tariq, Muhammad Waqas Tahir, Zoya Tahir, Faizan Zaheer, Abdul Wahab
doi : 10.1093/ibd/izac015.055
BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG PATIENTS WITH CROHN’S DISEASE: ANALYSIS OF THE NATIONWIDE READMISSION DATABASE
Ahmed Abomhya, Mohammed Mahmoodurrahman, Daniel Mozell, Salman Ayaz, Hossam Hamad
doi : 10.1093/ibd/izac015.056
CHRONIC COLITIS IN MICE INDUCES KIDNEY INJURY: TRANSLATIONAL IMPLICATIONS FOR IBD
Gloria Ducasa, Hajar Hazime, Irina Fernandez, Nivis Brito, Ana Santander, Juan Burgueno, Maria Abreu
doi : 10.1093/ibd/izac015.057
COMPLICATIONS OF MYOCARDITIS IN INFLAMMATORY BOWEL DISEASE (IBD): A POPULATION-BASED COMPARATIVE STUDY BETWEEN ULCERATIVE COLITIS AND CROHN’S DISEASE
Neethi Dasu, Yaser Khalid, Brian Blair, Christopher Chhoun, Lucy Joo
doi : 10.1093/ibd/izac015.058
CROHN’S DISEASE AND ACUTE PANCREATITIS; ASSOCIATION, OUTCOMES, AND PREDICTORS OF 90-DAY READMISSION WITH ACUTE PANCREATITIS. INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE
Ahmed Abomhya, Elizabeth Clemeston, Vijay Gayam, Farrah Khan, Denzil Etienne
doi : 10.1093/ibd/izac015.059
CURRENT VENOUS THROMBOEMBOLISM CHEMOPROPHYLAXIS PRACTICES AFTER SURGERY FOR IBD: SAVES-IBD TRIAL INITIAL REPORT
Stefan Holubar, Samuel Eisenstein, Liliana Bordeianou, Jeffrey Scow, Christopher Prien, Randolph Steinhagen, Alessandro Fichera, Tracy Hull
doi : 10.1093/ibd/izac015.060
ENDOSCOPIC STRICTUROTOMY – A NOVEL THERAPEUTIC MODALITY FOR IBD-RELATED STRICTURES: FIRST EUROPEAN EXPERIENCE
Martin Lukas, Martin Kolar, Martin Vasatko, Milan Lukas
doi : 10.1093/ibd/izac015.061
MICROSCOPIC COLITIS IS ASSOCIATED WITH DECREASED BONE DENSITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Natapat Chaisidhivej, Aunchalee Jaroenlapnopparat, Ben Ponvilawan, Nessa Tantivit, Michael E Goldberg
doi : 10.1093/ibd/izac015.062
NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN CROHN’S DISEASE PATIENTS BEING EVALUATED FOR INFLAMMATORY SPONDYLOARTHRITIS - A PILOT STUDY
Monica Schwartzman, Randy Longman, Ellen Scherl, Sergio Schwartzman
doi : 10.1093/ibd/izac015.063
NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE
Monica Schwartzman, Sergio Schwartzman
doi : 10.1093/ibd/izac015.064
PAIN IN INFLAMMATORY BOWEL DISEASE (IBD): DOES OPIOID USE PREDICT WORSE HOSPITAL OUTCOMES?
Neethi Dasu, Yaser Khalid, Brian Blair, C Jonathan Foster
doi : 10.1093/ibd/izac015.065
THE IMPACT OF CARDIAC ARRHYTHMIAS ON INFLAMMATORY BOWEL DISEASE (IBD)
Neethi Dasu, Yaser Khalid, Brian Blair, Justin Derosa, Drew Chiesa
doi : 10.1093/ibd/izac015.066
THE OPIOID EPIDEMIC: ASSESSING OUTCOMES OF OPIOID ABUSE IN CHRONIC INFLAMMATORY DISEASE (ULCERATIVE COLITIS VS CROHN’S DISEASE)
Neethi Dasu, Yaser Khalid, Brian Blair, Justin Derosa, Donald McMahon
doi : 10.1093/ibd/izac015.067
COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
Fabio Gil, Fabian Julian-Banos, Luisa Amador, Natalia Castano, Juan Reyes
doi : 10.1093/ibd/izac015.068
GEOGRAPHIC DIFFERENCES IN THE RISK OF SURGERY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Tawnya Hansen, Joyce Mak, Fox Underwood, Joseph Windsor, James King, Joshua Quan, Michael Buie, Stephanie Coward, Alex Frolkis, Alexander Leung, Christopher Ma, Kerri Novak, Remo Panaccione, Yiming Qian, Johan Burisch, Richard Gearry, Siew Ng, Gilaad Kaplan
doi : 10.1093/ibd/izac015.069
GLOBAL HOSPITALIZATION TRENDS FOR CROHN’S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES
Michael Buie, Joshua Quan, Joseph Windsor, Stephanie Coward, Richard Gearry, Tawnya Hansen, James King, Paulo Kotze, Siew Ng, Joyce Mak, Remo Panaccione, Cynthia Seow, Fox Underwood, Gilaad Kaplan
doi : 10.1093/ibd/izac015.070
IMPACT OF CURRENT AND FORMER SMOKING ON THE RISK OF ULCERATIVE COLITIS AMONG FAMILY HISTORY POSITIVE AND NEGATIVE INDIVIDUALS; EVIDENCE FOR GENE-SMOKING INTERACTION FROM LARGE SCALE POPULATION-BASED COHORT STUDY IN KOREA
Hyeong Sik Ahn, Hyun Jung Kim
doi : 10.1093/ibd/izac015.071
INCIDENCE AND PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS OF POPULATION-BASED STUDIES
Jared Cooper, Ante Markovinovic, Stephanie Coward, Aziz Shaheen, Mark Swain, Remo Panaccione, Christopher Ma, Kerri Novak, Gilaad Kaplan
doi : 10.1093/ibd/izac015.072
PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION
Tanya Zeina, Shiv Gandhi, Akaash Mittal, Alexander Levy, Joel Weinstock, Sushrut Jangi
doi : 10.1093/ibd/izac015.073
SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
Joshua Quan, Christopher Ma, Remo Panaccione, Jamil Kanji, Graham Tipples, Nastaran Sharifi, Michelle van Huyssteen, Ante Markovinovic, LeeAnn Turnbull, Gurmeet Bindra, Douglas Mahoney, Richard Ingram, Lindsay Hracs, Stephanie Coward, Joseph Windsor, Michael Buie, Melissa Chan, Jose Ferraz, Cathy Lu, Meena Mathivanan, Kerri Novak, Cynthia Seow, Tushar Shukla, Gilaad Kaplan
doi : 10.1093/ibd/izac015.074
DECREASED EXPRESSION OF NHE3 IN COLON CANCER EPITHELIUM IS ASSOCIATED WITH DNA DAMAGE, INCREASED LOCAL INFLAMMATION AND TUMOR GROWTH
Daniel Laubitz, Michael Gurney, Monica Midura-Kiela, Christy Clutter, Hao Chen, Fayez Ghishan, Pawel Kiela
doi : 10.1093/ibd/izac015.075
EPITHELIAL DUOX2 ACTIVATION INCREASES GUT PERMEABILITY AND BACTERIAL TRANSLOCATION THAT IS RESCUED WITH BUTYRATE SUPPLEMENTATION
Hajar Hazime, Gloria Ducasa, Irina Fernandez, Nivis Brito, Ana Santander, Judith Pignac-Kobinger, Gregory Conner, Juan Burgueno, Maria Abreu
doi : 10.1093/ibd/izac015.076
ILEAL ENTEROCYTE BRUSH BORDER ABNORMALITIES ASSOCIATE WITH PROGRESSIVE DISEASE COURSE IN PEDIATRICS CROHN’S DISEASE
Yael Haberman, Jefferson Vallance, Julie Baverman, Ta-Chiang Liu, Subra Kugathasan, Lee Denson, Kelli Van Dussen
doi : 10.1093/ibd/izac015.077
MATRIX METALLOPROTEINASE (MMP-9) INDUCED INCREASE IN INTESTINAL EPITHELIAL TIGHT JUNCTION BARRIER IS MEDIATED BY EGFR ACTIVATION
Rana Al-Sadi, Jessica Engers, Mohammad Haque
doi : 10.1093/ibd/izac015.078
METHYLTRANSFERASE SMYD2 MODULATES THERAPEUTIC EFFECTS OF EPIDERMAL GROWTH FACTOR IN INFLAMMATORY BOWEL DISEASE
Xiaoqing Guan, Yuning Hou, Shaligram Sharma, Chunying Li
doi : 10.1093/ibd/izac015.079
NEW OXPHOS REGULATING COMPOUND – AUPHOS – INCREASES MITOCHONDRIAL COMPLEXES EXPRESSION IN MURINE AND HUMAN INTESTINAL EPITHELIAL CELLS
Ahmed Elsayed, Ahmed Abomhya, Margarita Avdiushko, Neeraj Kapur, Samuel Awuah, Terrence Barrett, Tatiana Goretsky
doi : 10.1093/ibd/izac015.080
NOVEL CONTRIBUTIONS OF CLAUDIN-4 TO EPITHELIAL BARRIER REGULATION AND COLITIS
Nitesh Shashikanth, Yunuo Liu, Tiaosi Xing, Jerrold Turner
doi : 10.1093/ibd/izac015.081
OXPHOS DRIVES CRYPT FISSIONING REQUIRED FOR HEALING OF IBD ULCERS
Ahmed Abomhya, Tatiana Goretsky, Neeraj Kapur, Courtney Perry, Margarita Avdiushko, Emily Bradford, Terrence Barrett
doi : 10.1093/ibd/izac015.082
PLIN2 IS AN ARYL HYDROCARBON RECEPTOR TRANSCRIPTIONAL TARGET AND MAY CONTRIBUTE TO MUCOSAL RESTITUTION
Deanna Davis, Matthew Ciorba, David Alvarado
doi : 10.1093/ibd/izac015.083
PPI ADMINISTRATION CAUSES COLONIC TIGHT JUNCTION BARRIER DYSFUNCTION VIA INCREASE INENETROCOCCUS FECALIS
Meghali Nighot, Nathan Morris, Prashant Nighot, Kofi Clarke, Thomas Ma
doi : 10.1093/ibd/izac015.084
GENETIC OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND PARKINSON’S DISEASE IMPLICATES THE ROLE OF ADAPTIVE IMMUNE RESPONSE IN THEIR COMORBIDITY
Thomas Otten, Jonathan Ayash, Wonjun Lee, Haoxiang Cheng, Anketse Debebe, Ke Hao, Lauren Peters, Johan Björkegren, Olivia Kalash, Mellissa Picker, Alexa Rendon, Jean-Frederic Colombel, Rachel Saunders-Pullman, Marcus Unger, Inga Peter
doi : 10.1093/ibd/izac015.085
A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DISEASE OF THE GUT
Courtney Crane, Justin Bowser, Rachael Fasnacht, Jennifer Gardell, Meghan Maurer, Susan Julien, Megan Templeton, Jon Henry Therriault, Kristine Swiderek
doi : 10.1093/ibd/izac015.086
ADHERENT-INVASIVEE. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS
Monica Viladomiu, Manirath Khounlotham, Belgin Dogan, Svetlana Lima, Ahmed Elsaadi, Jeremy Herzog, Alexi Schoenborn, Melissa Ellermann, Bo Liu, Shiying Zhang, Ajay Gulati, R Balfour Sartor, Kenneth Simpson, Steve Lipkin, Randy Longman
doi : 10.1093/ibd/izac015.087
ALTERED MICROBIAL BIOGEOGRAPHY IN INNATE IMMUNE-MEDIATED COLITIS
Antonia Boger-May, Diana La La Torre, Katelyn Ruley-Haase, Lauren English, Connor Roncagli, Theodore Reed, Hunter Hoffman, Anne-Marie Overstreet, David Boone
doi : 10.1093/ibd/izac015.088
CHRONIC COLITIS ALTERS BRAIN ACTIVITY BY INDUCING HMGB1-MEDIATED PYROPTOSIS IN MICE
Jonathon Mitchell, Su Jin Kim, Cody Howe, Marisa Patel, Gayoung Kim, Gwangbeom Heo, Eunok Im, Sang Rhee
doi : 10.1093/ibd/izac015.089
GENERATION OF HUMAN INTESTINAL ORGANOIDS CONTAINING TISSUE-RESIDENT IMMUNE CELLS
Kentaro Tominaga, Dan Kechele, Guillermo Sanchez, Heather McCauley, Jacob Enriquez, Simon Vales, Ingrid Jurickova, Lee Denson, Takanori Takebe, Michael Helmrath, Aaron Zorn, James Wells
doi : 10.1093/ibd/izac015.090
INTERLEUKIN 21-INDUCED METABOLIC REPROGRAMMING DRIVES CD4 T CELL INFLAMMATORY RESPONSE DURING INTESTINAL INFLAMMATION
Adebowale Bamidele, Mary Sagstetter, Petra Hirsova, Guilherme Piovezani Ramos, Emily Klatt, Maria Westphal, William Faubion
doi : 10.1093/ibd/izac015.091
MASS CYTOMETRY ANALYSIS OF CROHN’S DISEASE-LIKE PHENOTYPE OF THE ILEOANAL POUCH FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE COLITIS
Siyan Cao, Marina Cella, Natalia Jaeger, Matthew Ciorba, Guadalupe Oliva Escudero, Alexandra Gutierrez, Richard Rood, Deborah Rubin, Parakkal Deepak, Marco Colonna
doi : 10.1093/ibd/izac015.092
NOD2 PROMOTES HOST DEFENSE AND RECOVERY INDUCING MACROPHAGE-MEDIATED INNATE LYMPHOID CELLS TYPE 3 ACTIVATION FOLLOWING FUNGAL INFECTION IN EXPERIMENTAL COLITIS
Morgan McAndrew, Hannah Havran, Luca Di Martino, Mahmoud Ghannoum, Theresa Pizarro, Carlo De Salvo
doi : 10.1093/ibd/izac015.093
NOVEL FUNCTION OF MYELOID METHYLTRANSFERASE SMYD5 IN INFLAMMATORY BOWEL DISEASE PROGRESSION
Yuning Hou, Xiaoqing Guan, Shaligram Sharma, Chunying Li
doi : 10.1093/ibd/izac015.094
THE ROLE OF GROUP 3 INNATE LYMPHOID CELLS (ILC3) IN GM-CSF/CSF2RB-DEPENDENT INTESTINAL HOMEOSTASIS IN CROHN’S DISEASE
Ling-shiang Chuang, Joshua Morrison, Zhi Chai, Ujunwa Korie, Arthur Mortha, Sacha Gnjatic, Judy Cho
doi : 10.1093/ibd/izac015.095
TNFAIP3 DRIVES COLITIS THROUGH DEATH CELL AND TNFα PRODUCTION
Alvaro Torres Huerta, Katelyn Ruley-Haase, Antonia Boger-May, David Boone
doi : 10.1093/ibd/izac015.096
A NOVEL MICROBIALLY-DERIVED PROTEIN CAN BE EXPRESSED INLACTOCOCCUS LACTIS AND DELIVERED ORALLY TO IMPROVE GUT BARRIER FUNCTION AND PREVENT FIBROGENESIS BY INTERACTING WITH THE EXTRACELLULAR MATRIX DURING GI INJURY
Chip La La Chat, Eskedar Nigatu, Elisabeth Messner, Bernat Baeza Raja, Jill Desnoyer, Amy Jo Johnson, Michi Willcoxon, Stefanie Banas, Andrew Han, Todd DeSantis, Karim Dabbagh, Irina Shilova, Lynn Yamamoto
doi : 10.1093/ibd/izac015.097
A NOVEL ORALLY ACTIVE METABOLITE REVERSES CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
Hon Wai Koon
doi : 10.1093/ibd/izac015.098
ACTIVATION OF MK2 IN CROHN’S DISEASE-ASSOCIATED FIBROSIS: NEW TARGET FOR ANTI-FIBROTIC THERAPY
Marina Chulkina, Steven McAninch, Melanie Ehudin, Claire Cohen, Sinisa Dovat, Walter Koltun, Gregory Yochum, Irina Pinchuk, Ellen Beswick
doi : 10.1093/ibd/izac015.099
EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE
Ingrid Jurickova, Alex Huron, Elizabeth Angerman, Erin Bonkowski, Anil Jegga, Yael Haberman, Lee Denson
doi : 10.1093/ibd/izac015.100
GPX3 IS REQUIRED TO MEDIATE PROTECTIVE EFFECTS OF GPX1 LOSS IN COLITIS
Koral Blunt, Justin Jacobse, Margaret Allaman, Mary Washington, Jeremy Goettel, Keith Wilson, Christopher Williams, Sarah Short
doi : 10.1093/ibd/izac015.101
INCREASE IN MK2 ACTIVITY IN CROHN’S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS
Marina Chulkina, Steven McAninch, Melanie Ehudin, Sinisa Dovat, Walter Koltun, Gregory Yochum, John Valentine, Ellen Beswick, Irina Pinchuk
doi : 10.1093/ibd/izac015.102
NIPEP-IBD; A SYNTHETIC PEPTIDE TARGETING NOVEL MOLECULE, INTEGRIN BETA 1, TO RESTITUTE INTESTINAL EPITHELIAL CELLS FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
Deogil Kim, Dong Woo Lee, Eui Kyun Jeong, Hoo Cheol Lee, Yoon Shin Park, Jue Yeon Lee, Chong Pyung Chung, Yoon Jeong Park
doi : 10.1093/ibd/izac015.103
TH17 CELLS PROMOTE INTESTINAL FIBROSIS THROUGH THE PRODUCTION OF AMPHIREGULIN
Wenjing Yang, Tianming Yu, Suxia Yao, Irina Pinchuk, Yingzi Cong
doi : 10.1093/ibd/izac015.104
LACTOBACILLUS MURINUS ACTIVATES THE ARYL HYDROCARBON RECEPTOR TO ATTENUATE TNF-ALPHA-INDUCED PRO-INFLAMMATORY RESPONSES IN HUMAN INTESTINAL EPITHELIAL CELLS
Husnain Ahmed, Julia Bell, Linda Mansfield
doi : 10.1093/ibd/izac015.105
RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS
Jeffrey Silber, Jason Norman, Tokuwa Kanno, Emily Crossette, Rose Szabady, Rajita Menon, Melissa Marko, Bernat Olle, Esi Lamousé-Smith
doi : 10.1093/ibd/izac015.106
SELECTION OF MICROBIOME-DERIVED PEPTIDES THROUGH MULTI-TECHNOLOGY META-ANALYSIS, BINDING, AND FUNCTIONAL ASSAYS, IDENTIFIES PEPTIDES WITH THERAPEUTIC POTENTIAL THAT MODULATE IMMUNE RESPONSES AND DISEASE
Michelle Lin, Eun Ok Kim, Jill Desnoyer, Nicole Narayan, Jayamary Ravichandar, Sabina Lau, Bum-Yeol Hwang, Amy Jo Johnson, Michi Willcoxon, Todd DeSantis, Karim Dabbagh, Lynn Yamamoto
doi : 10.1093/ibd/izac015.107
BRAIN FOG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, AND ASSOCIATION WITH USE OF PROBIOTICS
Apaar Dadlani, Khushboo Gala, Jayesh Rai, Shesh Rai, Gerald Dryden
doi : 10.1093/ibd/izac015.108
COMPARING THE GUT METABOLOMIC PROFILES IN HISPANIC AND NON-HISPANIC PEDIATRIC ULCERATIVE COLITIS PATIENTS
Parastou Khalessi Hosseini, Sonia Michail
doi : 10.1093/ibd/izac015.109
FECAL MICROBIOTA OF PEOPLE WITH CROHN’S DISEASE DOES NOT CHANGE WITH ILEOCECAL RESECTION
Daphne Moutsoglou, Alexander Khoruts, Byron Vaughn
doi : 10.1093/ibd/izac015.110
INTESTINAL EPITHELIAL CELL-SPECIFIC CFTR KNOCKOUT MICE EXHIBIT FECAL MICROBIAL DYSBIOSIS
Sarah Young, Aaron Ericsson, Rowena Woode, Lane Clarke
doi : 10.1093/ibd/izac015.111
KLEBSIELLA PNEUMONIAE IN THE COLONIC MUCUS LAYER INFLUENCESCLOSTRIDIODES DIFFICILE PATHOGENESIS
Taylor Ticer, Rachel Stine, Amy Engevik, Melinda Engevik
doi : 10.1093/ibd/izac015.112
THE MICROBIAL LANDSCAPE OF ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION
Sushrut Jangi, Glenn Robison, Paola Sebastiani, Jimmy Crott, Joel Weinstock, Siddharth Singh, Dominique Michaud
doi : 10.1093/ibd/izac015.113
THE SYNTHETIC GLYCAN KB295 OPTIMIZES MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS – RESULTS FROM A PROOF OF PRINCIPLE HUMAN STUDY
Jeffrey Meisner, Toni Bransford, Kelsey Miller, Jackson Lee, Adarsh Jose, Michael Giuggio, Megan McComb, Eric Humphries, Madeline Rosini, Mark Wingertzahn, Fergus Shanahan, Johan E T van Hylckama Vlieg, Mark Dowling
doi : 10.1093/ibd/izac015.114
TRENDS IN ADMISSIONS, OUTCOMES AND FINANCIAL BURDEN OFC. DIFFICILE INFECTION RELATED HOSPITALIZATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS: A NATIONWIDE ANALYSIS
Muhammad Waqas Tahir, Raseen Tariq, Zoya Tahir, Arsalan Zaheer, Sahil Khanna
doi : 10.1093/ibd/izac015.115
CLINICAL FEATURES AND OUTCOMES OF PAEDIATRIC PATIENTS WITH ISOLATED COLONIC CROHN’S DISEASE: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN
Tal Berger, HPaolo Lionetti, Luca Scarallo, Marco Gasparetto, Nicholas M Croft, Erasmo Miele, Annamaria Staiano, Joseph Meredith, Marina Aloi, Patrizia Alvisi, Darja Urlep, Batia Weiss, Mikkel Malham, Manar Matar, VÃctor Navas-López, Claudio Romano, Valeria Dipasquale, Lorenzo Norsa, Kaija-Leena Kolho, Raanan Shamir, Dror Shouval uey Miin Lee, Lavenya Ramasamy Padmanaban, Eytan Wine, Anat Yerushalmy-Feler, Iva Hojsak, Denis Kazeka, Daniela Elena Serban, Dotan Yogev, Oren Ledder,
doi : 10.1093/ibd/izac015.116
COMPARISON OF THE INFLAMMATORY BOWEL DISEASES PHENOTYPE AND COURSE IN THE ELDERLY- AND EARLY-ONSET PATIENTS
Bahar Saberzadeh-Ardestani, Amir Anushiravani, Bardia Khosravi, Homayoon Vahedi, Masoud Malekzadeh, Sudabeh Alatab, Anahita Sadeghi, Ali Reza Sima, Reza Malekzadeh
doi : 10.1093/ibd/izac015.117
DEVELOPMENT AND VALIDATION OF THE CROHN’S DISEASE-HEALTH INDEX (CD-HI), A CLINICALLY-RELEVANT, DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE
Jamison Seabury, Jennifer Weinstein, Spencer Rosero, Anika Varma, Ellen Wagner, Christine Zizzi, Nuran Dilek, Michael McDermott, Aaron Kaat, Lawrence Saubermann, Larissa Temple, Scott Rogoff, Chad Heatwole, Zach Rose
doi : 10.1093/ibd/izac015.118
IMPACT OF TIMING OF INITIATION OF INFLIXIMAB ON THE RISK OF IBD-RELATED SURGERY AND COMPLICATIONS
Denise Young, Aravind Thavamani, Jaime Perez, Jonathan Moses
doi : 10.1093/ibd/izac015.119
INCIDENTALLY DIAGNOSED ASYMPTOMATIC CROHN’S DISEASE: LONG-TERM CLINICAL OUTCOMES OF UNTREATED PATIENTS
Ana Grinman, Bella Ungar, Adi Lahat, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin
doi : 10.1093/ibd/izac015.120
INFLAMMATORY BOWEL DISEASE IN APPALACHIA: AN INVESTIGATION INTO DISPARATE OUTCOMES WITHIN THE STATE OF KENTUCKY
Courtney Perry, Christian Rhudy, Deborah Flomenhoft, Jeffrey Talbert, Terrence Barrett
doi : 10.1093/ibd/izac015.121
LONG TERM ADVERSE HEALTH OUTCOMES IN OFFSPRING FROM MOTHERS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE POPULATION BASED STUDY IN KOREA
Hyeong Sik Ahn, Hyun Jung Kim
doi : 10.1093/ibd/izac015.122
OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA)
Jessica Petrov, Badr Al-Bawardy, Jill Gaidos, Deborah Proctor
doi : 10.1093/ibd/izac015.123
PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD
Amr Sayed, Marina Silveira, David Assis, Yanhong Deng, Jill Gaidos, Deborah Proctor, Badr Al-Bawardy
doi : 10.1093/ibd/izac015.124
RELATIONSHIP BETWEEN SELF-REPORTED SLEEP AND DISEASE ACTIVITY DIFFERS BASED ON ENDOSCOPIC OR CLINICAL DISEASE ACTIVITY MEASURES
Kendra Kamp, Kindra Clark-Snustad, Linda Yoo, Diana Buchanan, Jeffrey Jacobs, Mitra Barahimi, Margaret Heitkemper, Scott D Lee
doi : 10.1093/ibd/izac015.125
UHPLC-MS/MS-BASED PLASMA LIPIDOMICS REVEAL ALTERATIONS ASSOCIATED WITH EXCLUSIVE ENTERAL NUTRITION TREATMENT IN ADULT PATIENTS WITH ACTIVE CROHN’S DISEASE
Qingfan Yang, ZiCheng Huang, Hailing Liu, Kang Chao, Xiang Gao
doi : 10.1093/ibd/izac015.126
COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: BURDEN AND IMPACT OF BOWEL URGENCY ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Stefan Schreiber, Simon Travis, Alison Potts Bleakman, Cem Kayhan, Hilary Ellis, Theresa Hunter, Eoin Flynn, Grzegorz Suldecki, Marla Dubinsky
doi : 10.1093/ibd/izac015.127
CONCORDANCE BETWEEN REMISSION DEFINED BY PATIENTS VS PATIENT-REPORTED OUTCOME MEASURES IN INFLAMMATORY BOWEL DISEASE
Kendra Kamp, Chung Sang Tse, Steven Hawes, Ridhima Oberai, Alandra Weaver, Siddharth Singh, Gil Melmed, Corey Siegel, Welmoed van Deen
doi : 10.1093/ibd/izac015.128
CROHN’S DISEASE COMPLICATED BY ILEOSIGMOID FISTULA: ASSESSMENT AND MANAGEMENT UPDATE
Sarah Benammi, Giacomo Calini, Solafah Abdalla, Kellie Mathis
doi : 10.1093/ibd/izac015.129
EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC
Karen Young, Devesh Hargunani, Vitaliy Poylin
doi : 10.1093/ibd/izac015.130
ENHANCED RECOVERY PROGRAMS: HOW ARE WE BENEFITTING PATIENTS WITH IBD?
Connie Shao, Marshall McLeod, Lauren Gleason, Isabel Marques, Burke Smith, Daniel Chu
doi : 10.1093/ibd/izac015.131
EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE
Michelle Kwon, Chung Sang Tse, Welmoed van Deen, Michael Danielewicz, Christopher Ward, Lawrence Kogan, Firrah Saeed, Samir Shah
doi : 10.1093/ibd/izac015.132
IBD AND THE PATIENT-PROVIDER RELATIONSHIP: DOES TRUST IMPACT TELEMEDICINE UTILIZATION?
Meghna Katta, Connie Shao, Ivan Herbey, Sagar Modi, Lauren Gleason, Isabel Marques, Teressa Duong, Elizabeth Lopez, Kaycee Hair, Daniel Chu
doi : 10.1093/ibd/izac015.133
IBD MIMICS PRESENTED AT IBD LIVE: WHEN IT IS NOT INFLAMMATORY BOWEL DISEASE
Christopher Ward, Samir Shah, Francis Farraye, Alka Goyal, John Hanson, Stefan Holubar, Andrew Watson, Steven Wexner, David Binion, Jill Gaidos, Tracy Hull, Badr Al-Bawardy, Jana Al Hashash, Myron Brand, Tanya Bruckel, Kofi Clarke, Benjamin Cohen, Raymond Cross, Jeffrey Dueker, Sean Fine, Erin Forster, Hans Herfath, Colleen Kelly, Mark Lazarev, L Campbell Levy, Amy Lightner, Taha Qazi, Joel Rosh, Abbas Rupawala, Corey Siegel, Miguel Regueiro
doi : 10.1093/ibd/izac015.134
IMPLICATIONS OF ADOLESCENT AND PARENT PERCIEVED SKILL-BUILDING ON MISCARREID HELPING AND SELF-EFFICACY FOLLOWING A TRANSITION WORKSHOP FOR ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE
Malika Waschmann, Henry Lin, Jacklyn Stellway
doi : 10.1093/ibd/izac015.135
IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Tony Cheng, Kyle Kreitman, Carissa Stowe, Bradford Waters, Leonard Baidoo
doi : 10.1093/ibd/izac015.136
LOCAL IBD-EXPERTS DISSATISFACTION WITH BIOLOGIC MEDICATION AUTHORIZATION DENIALS - A SURVEY OF SPECIFIC CLINICAL SCENARIOS
Leah DeCoste, Randall Pellish
doi : 10.1093/ibd/izac015.137
MEDICAL DECISION-MAKING AND EDUCATION RELATED TO OSTOMY SURGERY IN PEDIATRIC PATIENTS WITH IBD: QUALITATIVE THEMES FROM MULTIDISCIPLINARY PROVIDER FOCUS GROUPS
Jennie David, Jennifer Dotson, Laura Mackner
doi : 10.1093/ibd/izac015.138
SECURE ELECTRONIC DOCUMENT SIGNING UPTAKE IN BIOLOGIC PRESCRIBING FOR IMMUNE MEDIATED DISEASES
Sowmya Sharma, Jennifer Jones, Michael Stewart
doi : 10.1093/ibd/izac015.139
A QUALITATIVE STUDY EXPLORING MEANINGFUL IMPROVEMENT IN BOWEL URGENCY AMONG ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Louise Newton, Aiste Guobyte, Shehan McFadden, Tara Symonds, Laure Delbecque, Jill Donaldson, April Naegeli
doi : 10.1093/ibd/izac015.140
CHANGE IN URGENCY STATUS AMONG ULCERATIVE COLITIS PATIENTS: UNDERSTANDING THE IMPACT OF TREATMENT CHANGES FROM THE COREVITAS INFLAMMATORY BOWEL DISEASE REGISTRY
Douglas Wolf, April Naegeli, Page Moore, Judson Janak, Margaux Crabtree, Mingyang Shan, Theresa Hunter, Angelina Sontag, Raymond Cross
doi : 10.1093/ibd/izac015.141
DECONSTRUCTING DISTRESS: STAKEHOLDER ENGAGEMENT FOR EVIDENCE-BASED, PATIENT-CENTERED INTERVENTIONS FOR THE MANAGEMENT OF IBD-ASSOCIATED PSYCHOLOGICAL DISTRESS
Courtney Heisler, Noelle Rohatinsky, Michael Stewart, Michael Vallis, Tiffany Shepherd, Lori Wozney, Christine Cassidy, Barbara Currie, Kelly Phalen-Kelly, Jessica Robar, Laura Targownik, Thea Huard, Emily Neil, Jennifer Jones
doi : 10.1093/ibd/izac015.142
EXPLORING SELF-MANAGEMENT CHALLENGES OF ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IN AN ONLINE INSTAGRAM SUPPORT COMMUNITY
Caeli Malloy, Susan Rawl, Wendy Miller
doi : 10.1093/ibd/izac015.143
FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES
Nicole Neiman, Kavya Anjur, Ann Ming Yeh, Rachel Bensen, Anava Wren
doi : 10.1093/ibd/izac015.144
FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS
Courtney Perry, Mahmoud Hashim, Ahmed Elmoursi, Ahmed Elkheshen, Adam Dugan, Deborah Flomenhoft, Amy Stuffelbeam, Terrence Barrett
doi : 10.1093/ibd/izac015.145
IDENTIFYING BARRIERS TO HEALTH MAINTENANCE IN MEDICALLY-UNDERSERVED PATIENTS WITH IBD: A QUALITATIVE STUDY
Juanita Belton, Natalie Sanfratello, Erika Gaitan, Alana LeBron, Sharmeel Wasan, Julie White, Alan Moss
doi : 10.1093/ibd/izac015.146
INCREASED PREVALENCE OF ANXIETY IN HOSPITALIZED CROHN’S DISEASE PATIENTS IN THE UNITED STATES: INSIGHTS FROM NATIONAL INPATIENT DATABASE FROM 2009 TO 2018
Abhishek Bhurwal, Hemant Mutneja, Sophia Pimpinelli, Marcella Pimpinelli, Darren Seril
doi : 10.1093/ibd/izac015.147
LONGITUDINAL STUDY OF THE IMPACT OF HEALTH CONFIDENCE ON INFLAMMATORY BOWEL DISEASE OUTCOMES AND HEALTHCARE UTILIZATION
Chung Sang Tse, Gil Melmed, Chien-Hsiang Weng, Samir Shah, Alandra Weaver, Brant Oliver, Glyn Elwyn, Corey Siegel, Welmoed van Deen
doi : 10.1093/ibd/izac015.148
PATIENTS’ PERSPECTIVES, EXPERIENCES, AND CONCERNS WITH CROHN’S PERIANAL FISTULAE: INSIGHTS FROM SOCIAL MEDIA PLATFORMS
Carine Khalil, Welmoed van Deen, Taylor Dupuy, Gaurav Syal, Corey Arnold, Susan Cazzetta, Pradeep Nazarey, Brennan Spiegel
doi : 10.1093/ibd/izac015.149
PEOPLE WITH IBD WANT TO TALK ABOUT SLEEP: RECOMMENDATIONS ON WHAT TO ASK AND HOW TO RESPOND TO SLEEP COMPLAINTS
Jessica Salwen-Deremer, Christina Jagielski, Michael Smith, Corey Siegel
doi : 10.1093/ibd/izac015.150
PREVALENCE AND IMPACTS OF POST-TRAUMATIC STRESS SYMPTOMS IN IBD PATIENTS FROM UNDER-REPRESENTED MINORY GROUPS
Josie McGarva, Tiffany Taft
doi : 10.1093/ibd/izac015.151
PROMOTING AT-HOME DISEASE MANAGEMENT OF IBD WITH A MULTIDISCIPLINARY DIGITAL THERAPY APP: SHORT-TERM RESULTS
Roeland Pater, Dandyano Zentveld, Lisa Booth
doi : 10.1093/ibd/izac015.152
REDEFINING HEALTHCARE: A NOVEL, SCIENCE-BASED, EXPERIENTIAL FRAMEWORK FOR IMPROVING PATIENT OUTCOMES IN INFLAMMATORY BOWEL DISEASE
Amanda Puckett, Amy Loftus, Andrew Kornfeld
doi : 10.1093/ibd/izac015.153
SELF-RATED HEALTH IN INFLAMMATORY BOWEL DISEASE CORRELATES WITH ANXIETY, DEPRESSION, CATASTROPHIC THINKING, AND DISEASE SEVERITY
Brooke Palmer, Megan Petrik, Kathryn Tomasino
doi : 10.1093/ibd/izac015.154
SEXUAL DYSFUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Magdalena Kaniewska, Konrad Lewandowski, Dorota Szydlarska, Grazyna Rydzewska
doi : 10.1093/ibd/izac015.155
STIGMA INTERNALIZATION IN NON-WHITE PATIENTS WITH IBD AND ITS RELATIONSHIP WITH PATIENT OUTCOMES
Nicolette Veracruz, Tiffany Taft
doi : 10.1093/ibd/izac015.156
STIGMA PERCEPTIONS IN NON-WHITE IBD PATIENTS AND RELATIONSHIPS WITH PATIENT OUTCOMES
Nicolette Veracruz, Tiffany Taft
doi : 10.1093/ibd/izac015.157
THE CROHN’S AND COLITIS DISTRESS SCALE: ASSESSING THE DOMAINS OF IMPACT IN YOUTH WITH IBD
Caroline Cummings, Jacklyn Stellway, Jennifer Paternostro, Maggie Stoeckel, Linda Muir, Michael Harris
doi : 10.1093/ibd/izac015.158
TRANSPORTATION ACCESS AND DELAY IN DIAGNOSIS FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
Nicole Zeky, Colleen LeBlanc, Elizabeth McDonough, Dedrick Moulton
doi : 10.1093/ibd/izac015.159
BIOLOGIC PRECISION DOSING IS NOW AVAILABLE AT THE BEDSIDE FOR CHILDREN AND ADULTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING INFLIXIMAB
Phillip Minar, Abigail Samuels, Tomoyuki Mizuno, Frank Menke, Aaron Vogt, Nieko Punt, Alexander Vinks
doi : 10.1093/ibd/izac015.160
PREDICTIVE PERFORMANCE OF DIFFERENT POPULATION PHARMACOKINETIC MODELS IN A REAL-WORLD COHORT OF CROHN’S DISEASE PATIENTS
Abigail Samuels, Nieko Punt, Jack Reifenberg, Tomoyuki Mizuno, Ruben Colman, Frank Menke, Aaron Vogt, Alexander Vinks, Phillip Minar
doi : 10.1093/ibd/izac015.161
REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE
Ruben Colman, Tomoyuki Mizuno, Jeffrey Hyams, Joshua Noe, Brendan Boyle, Lee Denson, Alexander Vinks, Phillip Minar
doi : 10.1093/ibd/izac015.162
AN ONLINE SURVEY AMONG US PATIENTS WITH IMMUNE-MEDIATED CONDITIONS: BELIEFS ABOUT BIOSIMILARS FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Gary Jacobson, Allan Gibofsky, Shannan O’Hara-Levi, Archie Franklin, Laurent Peyrin-Biroulet, Melissa McGrath, Dorothy McCabe
doi : 10.1093/ibd/izac015.163
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
Karin Cerna, Dana Duricova, Martin Lukas, Nadezda Machkova, Veronika Hruba, Milan Lukas
doi : 10.1093/ibd/izac015.164
BEZLOTOXUMAB THERAPY FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN AN ULCERATIVE COLITIS PATIENT
Aaron Fein, Cody Kern, Rana Mohamed, Terrence Barrett, Courtney Perry
doi : 10.1093/ibd/izac015.165
BIOLOGICAL THERAPY AND POST-OPERATIVE OUTCOMES IN CROHN’S DISEASE PATIENTS UNDERGOING REPEAT ILEOCOLIC RESECTION
Nir Horesh, Michael Freund, Zoe Garoufalia, Rachel Gefen, David Zhang, Timothy Smith, Steven Wexner
doi : 10.1093/ibd/izac015.166
COMBINATION BIOLOGIC AND SMALL MOLECULE THERAPY FOR REFRACTORY ULCERATIVE COLITIS
Kaitlyn Hickman, Ronald Jordan, William Sonnier
doi : 10.1093/ibd/izac015.167
COMBINATION USTEKINUMAB AND VEDOLIZUMAB THERAPY FOR REFRACTORY INFLAMMATORY BOWEL DISEASE: A SINGLE INSTITUTION CASE SERIES
Nabila Dawoud, Lucas Roy, Ahmed Elmoursi, Mahmoud Elkammar, Mohamed Eltaher, Terrence Barrett, Courtney Perry
doi : 10.1093/ibd/izac015.168
COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
Emily Spiera, Danielle Ganjian, Xian Zhang, Erica Brenner, Manasi Agrawal, Jean-Frederic Colombel, Michael Kappelman, Asher Kornbluth, Ryan Ungaro
doi : 10.1093/ibd/izac015.169
DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY BOWEL DISEASES: DATA FROM CLINICAL PRACTICE
Milan Lukas, Martin Kolar, Martin Vasatko, Martin Lukas, Dana Duricova, Nadezda Machkova, Veronika Hruba, Karin Cerna, Kristyna Kastylova, Kristyna Kubickova
doi : 10.1093/ibd/izac015.170
EARLY VERSUS DELAYED INITIATION OF VEDOLIZUMAB IN ULCERATIVE COLITIS: TREATMENT RESPONSE IN THE REAL WORLD (RALEE)
Noa Cleveland, Ninfa Candela, John Carter, Maja Kuharic, Joyce Qian, Lily Tang, Robin Turpin, David Rubin
doi : 10.1093/ibd/izac015.171
EFFICACY OF LOW DOSE NALTREXONE IN PATIENTS WITH CROHN’S COLITIS AND ILEITIS
Leonard Weinstock
doi : 10.1093/ibd/izac015.172
HIGH DOSE TOFACITINIB AS SALVAGE THERAPY IN STEROID REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS FOLLOWING NON-RESPONSE TO INFLIXIMAB
Muhammad Khan, Kamran Mushtaq, Rafie Yakoob, Deema AlSoub
doi : 10.1093/ibd/izac015.173
IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE
Ahmad Nawaz, Laura Glick, Darrick Li, Jill Gaidos, Deborah Proctor, Badr Al-Bawardy
doi : 10.1093/ibd/izac015.174
REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: INITIAL RESULTS FROM A LARGE TERTIARY CENTER
Nathaniel Cohen, Tenzin Choden, David Choi, Noa Cleveland, Russell Cohen, Sushila Dalal, Atsushi Sakuraba, Ira Hanan, David Rubin
doi : 10.1093/ibd/izac015.175
REAL-WORLD UTILIZATION OF ADALIMUMAB BIOSIMILAR (ABP 501) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EUROPE
Ran Jin, Chidozie Nduka, Delphine Courmier, Hannah Knight, Rachael Meadows, James Piercy, Waldemar Radziszewski
doi : 10.1093/ibd/izac015.176
SUCCESSFUL CLEARANCE OF CYTOMEGALOVIRUS COLITIS IN ACUTE SEVERE ULCERATIVE COLITIS DURING INDUCTION OF OZANIMOD
Rana Mohamed, Cody Kern, Aaron Fein, Terrence Barrett, Courtney Perry
doi : 10.1093/ibd/izac015.177
VEDOLIZUMAB AS TREATMENT FOR COMMON VARIABLE IMMUNE DEFICIENCY (CVID): A CASE SERIES AND BRIEF REVIEW OF THE LITERATURE
Sagar Patel, Cameron Wilhoit, Kelli Williams, Erin Forster
doi : 10.1093/ibd/izac015.178
VEDOLIZUMAB FOR REFRACTORY MICROSCOPIC COLITIS: A CASE SERIES
Nabila Dawoud, Aaron Fein, Mahmoud Elkammar, Mohamed Eltaher, Terrence Barrett, Courtney Perry
doi : 10.1093/ibd/izac015.179
WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS
Andrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, Simon Lichtiger, Josep Bassaganya-Riera
doi : 10.1093/ibd/izac015.180
